You have 9 free searches left this month | to do more
Showing 1 - 25 of
1,240 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
Z
Effects of Metabolic Enzymes and Transporter Gene Polymorphisms on the Pharmacokinetics and Metabolism of Oral Abiraterone Acetate in Healthy Chinese Adults
Active, not recruiting
  • Abiraterone Acetate
  • +4 more
  • Abiraterone acetate tablets
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
2021-12-30
Dec 30, 2021
A
Study of Dose Escalation of Abiraterone Actetate in Prostate Cancer - 2021
Completed
  • Prostate Cancer
  • Abiraterone acetate standard dose
  • Abiraterone acetate escalated dose
  • Paris, France
    Department of Medical Oncology, Cochin Hospital
2022-01-21
Jan 21, 2022
A
Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of Ascending Doses of ARN 509 in Combination With Abiraterone Acetate
Active, not recruiting
  • Prostate Cancer
  • Boston, Massachusetts
    (unnamed)
2022-03-24
Mar 24, 2022
A
A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer
Active, not recruiting
  • Prostatic Neoplasms
  • Metastatic Castration-Resistant Prostate Cancer
  • Abiraterone Acetate
  • +2 more
  • Los Angeles, California
  • +6 more
2022-03-24
Mar 24, 2022
J
Comparative Study of Abiraterone Acetate Tablets (I) or ZYTIGA® in Patients With Metastatic Castration-resistant Prostate Cancer - 2022
Completed
  • Metastatic Castration-resistant Prostate Cancer (mCRPC)
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
2022-02-16
Feb 16, 2022
U
Erdafitinib and Abiraterone Acetate or Enzalutamide in Treating Patients With Double Negative Prostate Cancer
Suspended
  • Castration-Resistant Prostate Carcinoma
  • +6 more
  • Abiraterone Acetate
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-02-09
Feb 9, 2022
W
TQB3616 Capsules Combined With Abiraterone Acetate Plus Prednisone in Metastatic Castration-Resistant Prostate Cancer
Not yet recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • Drug Therapy, Combination
  • TQB3616 Capsules Combined With Abiraterone Acetate Plus Prednisone
  • Chengdu, Sichuan, China
    West China Hospital
2021-12-12
Dec 12, 2021
T
Bioequivalence of Abiraterone Acetate Tablets in Healthy Chinese Volunteers - 2018
Completed
  • Healthy Volunteers
  • Abiraterone acetate tablets(Zecke ®250 mg);Abiraterone acetate tablets(250 mg)
  • Qingdao, Shangdong, China
    Phase I Clinical Research Center
2021-04-26
Apr 26, 2021
F
Pharmacokinetic Food-effect Study of Abiraterone Acetate (AA) in Castration Resistant Prostate Cancer - 2020
Completed
  • Prostate Cancer
  • AA Reduced dose-normal diet (A)
  • +2 more
  • Seville, Spain
    Hospital Universitario Virgen del Rocío
2021-01-08
Jan 8, 2021
M
Abiraterone Acetate for Castrate Resistant Prostate Cancer
Active, not recruiting
  • Prostate Cancer
  • Boston, Massachusetts
    Massachusetts General Hospital
2021-02-08
Feb 8, 2021
F
Abiraterone Acetate in Patients With Relapsed and/or Metastatic Salivary Gland Cancers - 2020
Completed
  • Salivary Glands Tumors
  • Abiraterone acetate
  • Milan, Lombardy, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
2021-03-01
Mar 1, 2021
D
Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy
Active, not recruiting
Has Results
  • Prostate Cancer
  • La Jolla, California
  • +3 more
2021-09-01
Sep 1, 2021
M
Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in Treatment of Metastatic Castration Resistant Prostate Cancer
Active, not recruiting
  • Prostate Cancer
  • Abiraterone acetate 1000 mg po daily
  • +2 more
  • New York, New York
  • +3 more
2021-09-01
Sep 1, 2021
C
Pharmacogenetic Study in Castration-resistant Prostate Cancer Patients Treated With Abiraterone Acetate - 2020
Completed
  • Pharmacogenetic Study
  • Abiraterone Acetate
  • Nice, France
    Centre Antoine Lacassagne
2020-12-03
Dec 3, 2020
U
Abiraterone Acetate in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer - 2020
Completed
Has Results
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Abiraterone Acetate
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-04-22
Apr 22, 2021
M
Combining Ipilimumab With Abiraterone Acetate Plus Prednisone in Chemotherapy and Immunotherapy-naïve Patients With Progressive Metastatic Castration-resistant Prostate Cancer
Active, not recruiting
  • Prostate Cancer
  • Evanston, Illinois
  • +2 more
2021-09-09
Sep 9, 2021
M
3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy - 2020
Completed
Has Results
  • Prostate Cancer
  • Abiraterone acetate
  • +2 more
  • Chicago, Illinois
  • +15 more
2021-10-25
Oct 25, 2021
J
A Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone Acetate - 2021
Completed
  • Metastatic Castration-resistant Prostate Cancer
  • Metastatic Breast Cancer
  • Aurora, Colorado
  • +21 more
2021-07-22
Jul 22, 2021
D
Men With Metastatic Castrate-Resistant Prostate Cancer Treated With Either Sipuleucel-T (Provenge®), Abiraterone Acetate (Zytiga®) or Enzalutamide (Xtandi®) Undergoing Cardiopulmonary EXercise Testing - 2018
Completed
  • Prostate Cancer
  • Durham, North Carolina
    Duke University Medical Center
2020-12-22
Dec 22, 2020
J
A Post-marketing Surveillance to Assess Safety of Abiraterone Acetate (Zytiga) in Indian Participants With Metastatic, Castration Resistant Prostate Cancer
Recruiting
  • Prostate Cancer
  • Abiraterone Acetate
  • Bangalore, India
  • +6 more
2022-03-24
Mar 24, 2022
D
Conventional ADT w/ or w/Out Abiraterone Acetate + Prednisone and Apalutamide Following a Detectable PSA After Radiation and ADT
Recruiting
  • Prostate Cancer
  • Boston, Massachusetts
  • +4 more
2021-11-01
Nov 1, 2021
M
Abiraterone With Discontinuation of Gonadotropin-Releasing Hormone Analogues in Metastatic Prostate Cancer
Active, not recruiting
  • Prostatic Neoplasms
  • Bronx, New York
    Montefiore Medical Center
2021-12-02
Dec 2, 2021
W
Neoadjuvant Therapy of Abiraterone Plus ADT for Intraductal Carcinoma of the Prostate
Not yet recruiting
  • Prostate Cancer
  • Abiraterone acetate
  • +2 more
  • Chengdu, Sichuan, China
    West China Hospital
2021-02-03
Feb 3, 2021
H
Adaptive Abiraterone Therapy for Metastatic Castration Resistant Prostate Cancer
Active, not recruiting
  • Prostate Cancer
  • Abiraterone Acetate
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2022-01-28
Jan 28, 2022
M
Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer
Active, not recruiting
  • Prostate Adenocarcinoma
  • Recurrent Prostate Carcinoma
  • Abiraterone Acetate
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-11-17
Nov 17, 2021